HBEAG CONCENTRATION CAN BE USED TO PREDICT RESPONSE AND MONITOR THE EFFECTS OF TREATMENT IN CHRONIC HEPATITIS-B - A COMPARISON TO HBV DNA TESTING

被引：0
|
作者：
PERRILLO, R
MIMMS, L
SCHECHTMAN, K
ROBBINS, D
CAMPBELL, C
机构：
[1] VAMC,GASTROENTEROL SECT,ST LOUIS,MO
[2] WASHINGTON UNIV,SCH MED,DEPT INTERNAL MED,ST LOUIS,MO 63110
[3] WASHINGTON UNIV,SCH MED,DEPT BIOSTAT,ST LOUIS,MO 63110
[4] ABBOTT LABS,N CHICAGO,IL 60064
来源：
HEPATOLOGY | 1993年 / 18卷 / 04期
关键词：
D O I：
10.1016/0270-9139(93)92111-C
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A146 / A146
页数：1
相关论文
共 50 条
  • [41] SKIN TESTING TO PREDICT IMMUNE-RESPONSE TO HEPATITIS-B VACCINE
    TORRE, D
    MAGGIOLO, F
    BROGGINI, M
    BOTTA, V
    LANCET, 1985, 2 (8458): : 783 - 784
  • [42] HEPATITIS-B VIRUS (HBV)-SPECIFIC T-CELL RESPONSE IN CHRONIC HBV INFECTION
    HU, CP
    SHU, PY
    SHEN, CH
    LIN, MY
    WU, JC
    CHANG, CM
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 291 - 291
  • [43] Prediction of the Response to Peg-Interferon-Alfa in Patients With HBeAg Positive Chronic Hepatitis B Using Decline of HBV DNA During Treatment
    Hansen, Bettina E.
    Buster, Erik H. C. J.
    Steyerberg, Ewout W.
    Lesaffre, Emmanuel
    Janssen, Harry L. A.
    JOURNAL OF MEDICAL VIROLOGY, 2010, 82 (07) : 1135 - 1142
  • [44] HBV DNA and HBsAg: Early Prediction of Response to Peginterferon α-2a in HBeAg-Negative Chronic Hepatitis B
    Zhang, Chong
    Yang, Zhengrong
    Wang, Ziyi
    Dou, Xiaoguang
    Sheng, Qiuju
    Li, Yanwei
    Han, Chao
    Ding, Yang
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2020, 17 (03): : 383 - 389
  • [45] PREDICTION OF RESPONSE TO PEGINTERFERON-ALFA IN HBEAG POSITIVE CHRONIC HEPATITIS B - INCREASED ACCURACY BY INCLUDING HBV DNA DECLINE DURING TREATMENT
    Hansen, Bettina E.
    Buster, Erik H.
    Steyerberg, Ewout W.
    Janssen, Harry L.
    HEPATOLOGY, 2008, 48 (04) : 726A - 727A
  • [46] EFFECTS OF INTERFERON-ALPHA THERAPY ON SERUM AND LIVER HBV DNA IN PATIENTS WITH CHRONIC HEPATITIS-B
    FEINMAN, SV
    BERRIS, B
    SOOKNANAN, R
    FERNANDES, B
    BOJARSKI, S
    DIGESTIVE DISEASES AND SCIENCES, 1992, 37 (10) : 1477 - 1482
  • [47] Predicting HBeAg loss by HBV DNA early kinetics and HBV genotype during treatment of HBeAg plus chronic hepatitis B (CHB) patients with adefovir dipivoxil (ADV)
    Neumann, AU
    Havlin, Y
    Ronen, T
    Tsiang, M
    Wulfsohn, M
    Brosgart, C
    Fry, J
    Westland, C
    Xiong, S
    Gibbs, CS
    JOURNAL OF HEPATOLOGY, 2003, 38 : 26 - 26
  • [48] HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients
    Peng, Cheng-Yuan
    Hsieh, Tsung-Cheng
    Hsieh, Tsai-Yuan
    Tseng, Kuo-Chih
    Lin, Chih-Lin
    Su, Tung-Hung
    Tseng, Tai-Chung
    Lin, Hans Hsienhong
    Wang, Chia-Chi
    Kao, Jia-Horng
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2015, 114 (04) : 308 - 313
  • [49] Monitoring serum HBV-DNA levels with the TaqMan technique during treatment of HBeAG(-) chronic hepatitis B with lamivudine
    Hadziyannis, AS
    Mitsoula, P
    Hadziyannis, ES
    Panopoulou, E
    Colucci, G
    Hadziyannis, SJ
    HEPATOLOGY, 2005, 42 (04) : 726A - 727A
  • [50] EFFECTS OF IMMUNOSTIMULANTS ON TREATMENT OF CHRONIC ACTIVE HEPATITIS-B
    SAKAGAMI, Y
    MIZOGUCHI, Y
    TSUTSUI, H
    YAMAMOTO, S
    DIGESTIVE DISEASES AND SCIENCES, 1986, 31 (10) : S190 - S190
12345